These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31170806)

  • 1. Precision oncology in patients with nonmetastatic disease: emerging reality or illusion.
    Antoniou P; Ziogas DE; Mitsis M; Roukos DH
    Future Oncol; 2019 Jun; 15(16):1805-1810. PubMed ID: 31170806
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision oncology: East meets West.
    Subbiah V; Rodon J; Yap TA
    Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
    [No Abstract]   [Full Text] [Related]  

  • 3. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 4. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
    Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
    An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical tumour sequencing for precision oncology: time for a universal strategy.
    Cheng ML; Berger MF; Hyman DM; Solit DB
    Nat Rev Cancer; 2018 Sep; 18(9):527-528. PubMed ID: 30030494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing access to next-generation sequencing in oncology for Brazil.
    Santos M; Coudry RA; Ferreira CG; Stefani S; Cunha IW; Zalis MG; Araujo LH
    Lancet Oncol; 2019 Jan; 20(1):20-23. PubMed ID: 30614460
    [No Abstract]   [Full Text] [Related]  

  • 10. The era of precision oncogenomics.
    Carpten JC; Mardis ER
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610397
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
    Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
    Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of next-generation sequencing in precision oncology.
    Hux A; Lewis A; Sachwitz D; Gregory T
    JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
    Bombard Y
    Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
    Gargallo P; Bautista F; Juan-Ribelles A; Izquierdo E; Soriano A; de Rojas T; Escudero A; Lavarino C; Solano P; Hladun R; Rubio-San-Simón A; Martínez-Romera I; Calabria I; Olaciregui NG; Castañeda-Heredia A; de Álava E; Pérez-Martínez A; Astigarraga I; Patiño-García A; Alonso J; Fernández-Teijeiro A; Cañete A; Moreno L
    Clin Transl Oncol; 2022 May; 24(5):809-815. PubMed ID: 35152364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Architecture of a Precision Oncology Platform.
    Laganà A
    Adv Exp Med Biol; 2022; 1361():1-22. PubMed ID: 35230680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Future of Precision Medicine in Oncology.
    Millner LM; Strotman LN
    Clin Lab Med; 2016 Sep; 36(3):557-73. PubMed ID: 27514468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.
    Schachtschneider KM; Gaba RC
    J Vasc Interv Radiol; 2018 Aug; 29(8):1117-1121. PubMed ID: 30055782
    [No Abstract]   [Full Text] [Related]  

  • 20. Should next-generation sequencing tests be performed on all cancer patients?
    McKenzie AJ; H Dilks H; Jones SF; Burris H
    Expert Rev Mol Diagn; 2019 Feb; 19(2):89-93. PubMed ID: 30618301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.